KIT and fibrosarcoma: Rather, KIT is routinely assessed by IHC as a diagnostic marker to distinguish between different cancer types, such as MCT (KIT IHC positive) versus lymphoma (KIT IHC negative), or GIST (KIT IHC positive) versus fibrosarcoma (KIT IHC negative).